Introduction of Psychiatric Biomarker Testing
For many years, researchers have been trying to identify diagnostic and prognostic biomarkers for psychiatric disorders, including schizophrenia, major (monophasic) depression and bipolar disorder. Identifying such biomarkers will help in the diagnosis of these disorders, as well as in the possible development of effective psychiatric drugs to treat them.
Fig. 1 Current and emerging treatment response biomarkers in anxiety disorders. (Strawn JR, et al., 2020)
Biomarker Testing Services
We provide end-to-end biomarker analysis during antipsychotic drug discovery and preclinical studies. Our scientists have extensive experience in establishing biomarker assays to quantify proteins, peptides and small molecules in various biological matrices such as blood, plasma, serum, urine, cerebrospinal fluid, organ tissue homogenates, etc. You can take advantage of our biomarker testing services for over 1,000 analytes on MSD, Luminex, ELISA, LC-MS/MS, qPCR and Western Blot.
- Predictive Biomarker Identification Services in Psychiatry
Our scientific experts and biomarker lab staff can help you develop a translational design strategy to identify, develop predictions for multiple biomarkers in parallel, so the most relevant biomarkers can be identified faster and give you early proof-of-concept.
- Biomarker Analysis Services in Psychiatry
We have extensive experience in the analysis of biomarkers of stress and other psychiatric disorders in a wide range of biological matrices. With years of experience in assay design and sample processing, we can provide high-quality biomarker analysis services to support your anti-psychotic drug discovery pipeline.
- Biomarker Validation Services in Psychiatry
We are dedicated to providing biomarker validation services to test the sensitivity, specificity, and analytical validity of our clients' biomarker candidates. We use systems biology and integrated platform approaches for biomarker validation, thus providing the best opportunity for the early identification of the biomarker for mental illness candidates.